A cluster-randomised cross-over trial

Transcription

1 A cluster-randomised cross-over trial Design of Experiments in Healthcare Isaac Newton Institute, Cambridge 15 th August 2011 Ian White MRC Biostatistics Unit, Cambridge, UK

2 Plan 1. The PIP trial 2. Why cluster-randomise? 3. Why cross-over? 4. Efficiency 5. Analyses 6. How widely useful is the cluster-crossover design? 2

3 1. The Parent-Baby Interaction Programme Pre-term birth (<32 weeks) places a child at high risk of neurological and psychological impairment possibly because the psychological stress associated with preterm birth adversely affects mother-infant interaction Hence the Parent-Baby Interaction Programme (PBIP), a nurse-led intervention to enhance the parent-infant relationship & help parents care appropriately for their preterm babies Hope for positive effects on infant cognitive outcomes 3

4 The Pre-term Infant Parenting (PIP) trial The PIP trial evaluated the Parent-Baby Interaction Programme in 6 neonatal centres in England 233 babies recruited from 210 mothers each centre admitted ~ 3 pre-term babies per month mean length of stay for each baby was ~ 2 months recruitment was spread over a year Intervention was delivered by specially trained research nurses Comparator was usual care Outcomes included parental stress at 3 months child s mental and physical development at 24 months 4

5 2. PIP: why cluster-randomise? Two main reasons to cluster-randomise: To avoid contamination: with ~ 6 pre-term babies in each centre at any one time, an individually-randomised trial would allow transfer of knowledge about the intervention from intervention to control parents For practical reasons: e.g. intervention delivered in fewer centres better compliance 5

6 Problems with cluster-randomising Possible recruitment bias recruitment must take place over time (as the babies are born) so must follow centre randomisation risk of differential consent between the two arms we addressed this» by trying to maximise consent rates (achieved 233/307=76%)» by monitoring consent rates to check they were similar across arms (80% intervention, 72% control) With only 6 centres, power is likely to be low addressed by the cross-over part of the design (see next) Analysis must allow for clustering 6

7 3. PIP: why cross-over? Cross-over trials are used in individually randomised designs to reduce the impact of between-individual variation (hence improving precision) Since clusters are likely to vary in their average outcomes, the same argument applies We allocated each centre to one intervention for 6 months, then the other intervention for 6 months order was randomised Allocation applied to all babies born in the centre within the 6-month period 7

8 Problems with cross-over design Possible carry-over: treatment in one period affects outcome in later periods in individually-randomised drug trials: drug still in system, or physiological or psychological effects remain in cluster-randomised trial like PIP: giving the intervention in period 1 could affect later outcomes through presence of the same individuals (parents & staff?) avoid carry-over by having an adequate wash-out period PIP: a 3-month wash-out separated the two periods Analysis must allow for pairing 8

9 Two cluster-randomised cross-over designs Relatively short stays, different patients in each period: Intervention Wash-out Control Long stays, same patients measured in each period: Intervention Wash-out Control 9

10 Carry-over Short stays Intervention Wash-out Control Need to avoid carry-over at institutional level e.g. by providing intervention through dedicated staff who aren t present in control period Long stays Intervention Wash-out Control Need to avoid carry-over at institutional and individual levels Only suitable for chronic diseases? 10

11 4. Efficiency A model for a CRXO trial: let x ij = treatment allocated to cluster i in period j let y ijk = outcome for individual k in period j in cluster i Model y bx u v e ijk j ij i ij ijk u 2 i ~ N( 0, u) 2 ij ~ N( 0, v ) 2 ijk ~ N( 0, e ) v e Here b is the intervention effect of primary interest 11

12 Efficiencies of 3 designs 3 designs with Kn individuals per arm: IRT: individually randomised trial with Kn individuals per arm, 1 period CRT: cluster-randomised trial with K clusters of size n per arm, 1 period CRXO: cluster-randomised cross-over trial with K/2 clusters of size n per arm, 2 periods We can compute efficiencies with equal cluster sizes for the estimated intervention effect is simply the difference of the means 12

13 Efficiencies of 3 designs Model IRT: var( ˆ b ) CRT: y bx u v e ijk j ij i ij ijk 1 K n n n u v e var( ˆ e b ) u v K n var( ˆ 1 CRXO: b) K 2 v n 2 e 2 CRT always inferior to IRT CRXO superior to IRT 2 2 if /( n 1) v if 0 2 u u CRXO superior to CRT NB: fewer degrees of freedom of CRXO trial also matters. 13

14 Two intra-cluster correlations (ICCs) ICC between periods (same cluster): / period v v e ICC between clusters: u v / u v e cluster Note period cluster 14

15 5. CRXO trial: analysis questions Should we use cluster-level analyses? based on cluster means easier to understand or individual-level analyses? based on hierarchical models With equal cluster sizes (i.e. each cluster recruits n individuals in each period), all methods give the same point estimates & all are unbiased even with unequal cluster sizes Main interest is in 1. Standard errors coverage 2. Efficiency with unequal cluster sizes 15

16 Individual-level analyses considered Model y ijk = j + b x ij + u i + v ij + e ijk v ij, e ijk always random M1: random cluster effects u i M2: fixed cluster effects u i M2(-): M1 and M2 constrain all random effect variances to be non-negative, but M2(-) has 2 v unconstrained All fit by REML 16

17 Cluster-level analyses considered Adapted from analysis of a cross-over trial Define d i = cross-over difference for cluster i: mean in intervention period mean in control period Define w i = x i2 x i1 = +1 if intcont, -1 if contint Intervention effect is b in model d i = b + gw i + e i Unweighted: fit model by OLS estimate: ½{ave d in intcont + ave d in contint} Weighted 1: fit model with weight = n i1 n i2 / (n i1 +n i2 ) Weighted 2: weight that also allows for ICCs Weights only matter with unequal cluster sizes 17

18 Simulation study: coverages with 6 clusters of equal sizes 20 individuals per cluster-period ICC period ICC cluster M1 99.5% 99.4% 99.7% 97.4% 97.5% 96.4% M2 99.6% 99.4% 99.7% 98.0% 97.5% 96.9% M2( ) 94.6% 94.2% 94.2% 94.8% 95.1% 95.1% Cluster-level (all methods) 94.6% 94.2% 94.2% 94.8% 95.1% 95.1% Forcing variance components 0 over-coverage. Cluster-level methods implicitly allow negative variance components. 18

19 Simulation study: empirical standard errors with 6 clusters of different sizes Cluster-period sizes = Poisson(m), m = 15 or 25 ICC period ICC cluster M M M2( ) Cluster unweighted n-weighted using ICC Unweighted cluster method has small loss of efficiency. 19

20 Simulation study: conclusions We analysed the trial using cluster-level methods with n i1 n i2 / (n i1 +n i2 ) weights We adjusted for individual-level baseline variables z by applying the cluster-level analysis to the residuals from an OLS regression of outcome on z But we assessed interactions (of intervention with individual-level covariates) using a hierarchical model 20

21 An awkward analysis point In a preliminary analysis, we found a negative estimated variance component, and hence the standard error allowing for clustering was lower than not allowing for clustering Felt that we would want to report the larger standard error in this case In other words we prefer M2 to M2(-) Correct coverage is not the most important thing? This situation can arise in all CRTs 21

22 6. Summary: advantages & disadvantages of a CRXO design Advantages Efficiency Convenience Disadvantages Recruitment bias is always a threat? can be avoided in 1-period CRTs by listing & consenting all individuals before randomisation, but this is unlikely in a 2-period CRT can arise if eligibility is under staff control (PIP: if staff could influence baby s date of birth unlikely) can arise through differential consent Analysis is somewhat complicated 22

23 When is the cluster-crossover design useful? Other examples of its use: compare 2 policies for ordering chest X-rays for ventilated intensive care patients (Lancet 2009; 374: )» is carry-over a risk? evaluate real-time audio-visual feedback about cardio-pulmonary resuscitation performed outside hospital (BMJ 2011; 342: d512)» clusters alternated between feedback-on and feedbackoff over 2-5 periods Seems ideal for evaluating policy-type interventions which can be switched on and off, provided recruitment bias can be avoided 23

24 Acknowledgements & references PIP trial: Sam Johnson, Cris Glazebrook, Chrissie Israel, Andrew Whitelaw, Neil Marlow Glazebrook C, Marlow N, Israel C, Croudace T, Johnson S, White IR, Whitelaw A. Randomised trial of a parenting intervention during neonatal intensive care. Archives of disease in childhood 2007; 92: Johnson S, Whitelaw A, Glazebrook C, Israel C, Turner R, White IR, Croudace T, Davenport F, Marlow N. Randomised trial of a parenting intervention for very preterm infants: Outcome at 2 years. Journal of Pediatrics 2009; 155: Methods project: Rebecca Turner, Tim Croudace Turner RM, White IR, Croudace T. Analysis of cluster randomised cross-over trial data: a comparison of methods. Statistics in Medicine 2007; 26: